BioXcel Therapeutics
BTAI
BTAI
70 hedge funds and large institutions have $117M invested in BioXcel Therapeutics in 2020 Q1 according to their latest regulatory filings, with 36 funds opening new positions, 16 increasing their positions, 17 reducing their positions, and 8 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more capital invested
Capital invested by funds: $ → $
more funds holding
Funds holding: →
more ownership
Funds ownership: →
6% less repeat investments, than reductions
Existing positions increased: 16 | Existing positions reduced: 17
7% less call options, than puts
Call options by funds: $4.06M | Put options by funds: $4.36M
Holders
70
Holding in Top 10
1
Calls
$4.06M
Puts
$4.36M
Top Buyers
| 1 | +$12M | |
| 2 | +$7.04M | |
| 3 | +$6.7M | |
| 4 |
Massachusetts Financial Services
Boston,
Massachusetts
|
+$6.13M |
| 5 |
APM
Avidity Partners Management
Dallas,
Texas
|
+$4.72M |
Top Sellers
| 1 | -$6.82M | |
| 2 | -$4.74M | |
| 3 | -$3.73M | |
| 4 |
DAM
DLD Asset Management
New York
|
-$956K |
| 5 |
BBVA
Banco Bilbao Vizcaya Argentaria
Madrid,
Spain
|
-$640K |